{
    "bc93caf7-1804-3cda-821d-cb45a0266514": {
        "uuid": "bc93caf7-1804-3cda-821d-cb45a0266514",
        "title": "Could This News From Moderna Mean Trouble for Novavax?",
        "publisher": "Motley Fool",
        "link": "https://finance.yahoo.com/m/bc93caf7-1804-3cda-821d-cb45a0266514/could-this-news-from-moderna.html",
        "providerPublishTime": 1655289000,
        "type": "STORY"
    },
    "62fc811a-6aa4-343a-970c-5a1d92d4ea38": {
        "uuid": "62fc811a-6aa4-343a-970c-5a1d92d4ea38",
        "title": "IBD/TIPP Poll: There's Bad News For Novavax's Covid Vaccine",
        "publisher": "Investor's Business Daily",
        "link": "https://finance.yahoo.com/m/62fc811a-6aa4-343a-970c-5a1d92d4ea38/ibd%2Ftipp-poll%3A-there%27s-bad.html",
        "providerPublishTime": 1655237417,
        "type": "STORY"
    },
    "7ac49bd3-3280-4492-bc96-8efeb4596cf1": {
        "uuid": "7ac49bd3-3280-4492-bc96-8efeb4596cf1",
        "title": "Health authorities push for a vaccine patent waiver to 'genuinely' prepare for the next pandemic",
        "publisher": "Yahoo Finance",
        "link": "https://finance.yahoo.com/news/health-authorities-push-for-a-vaccine-patent-waiver-152542100.html",
        "providerPublishTime": 1655220342,
        "type": "STORY"
    },
    "ecb9ef65-2cb2-378d-b09a-2d564c2fa465": {
        "uuid": "ecb9ef65-2cb2-378d-b09a-2d564c2fa465",
        "title": "Novavax' Sees Conditional Approval Of COVID-19 Vaccine Booster In Australia As US FDA Delays Its Decision",
        "publisher": "Benzinga",
        "link": "https://finance.yahoo.com/news/novavax-sees-conditional-approval-covid-150614240.html",
        "providerPublishTime": 1655132774,
        "type": "STORY"
    },
    "2ca4871c-28d4-349d-948b-9f80c5148890": {
        "uuid": "2ca4871c-28d4-349d-948b-9f80c5148890",
        "title": "Novavax COVID-19 Vaccine Nuvaxovid\u2122 Provisionally Registered in Australia as a Booster in Individuals Aged 18 and Over",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/novavax-covid-19-vaccine-nuvaxovid-110000784.html",
        "providerPublishTime": 1655118000,
        "type": "STORY"
    },
    "be3258a2-feac-3641-8bcc-b1f20b1a2d87": {
        "uuid": "be3258a2-feac-3641-8bcc-b1f20b1a2d87",
        "title": "Should You Worry About Novavax's Latest Delay?",
        "publisher": "Motley Fool",
        "link": "https://finance.yahoo.com/m/be3258a2-feac-3641-8bcc-b1f20b1a2d87/should-you-worry-about.html",
        "providerPublishTime": 1655114400,
        "type": "STORY"
    },
    "e9809838-7529-36d6-b238-618ca4cd9684": {
        "uuid": "e9809838-7529-36d6-b238-618ca4cd9684",
        "title": "Novavax Stock: Bull vs. Bear",
        "publisher": "Motley Fool",
        "link": "https://finance.yahoo.com/m/e9809838-7529-36d6-b238-618ca4cd9684/novavax-stock%3A-bull-vs.-bear.html",
        "providerPublishTime": 1655028240,
        "type": "STORY"
    },
    "65ab04fc-c07f-3086-ae5c-d4918c2ed35a": {
        "uuid": "65ab04fc-c07f-3086-ae5c-d4918c2ed35a",
        "title": "5 Cutting-Edge Growth Stocks That Can Turn $200,000 Into $1 Million by 2030",
        "publisher": "Motley Fool",
        "link": "https://finance.yahoo.com/m/65ab04fc-c07f-3086-ae5c-d4918c2ed35a/5-cutting-edge-growth-stocks.html",
        "providerPublishTime": 1655024760,
        "type": "STORY"
    }
}